menu
    • menu
    [{"orgOrder":0,"company":"AskGene Pharma Inc","sponsor":"GenScript ProBio","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"U.S.A","productType":"Large molecule","year":"2021","type":"Licensing Agreement","leadProduct":"Single-domain Antibody","moa":"Checkpoint","graph1":"Oncology","graph2":"Discovery","graph3":"AskGene Pharma Inc","amount2":0,"highestDevelopmentShortName":"Discovery","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"","sponsorNew":"AskGene Pharma Inc \/ AskGene","highestDevelopmentStatusID":"2","companyTruncated":"AskGene Pharma Inc \/ AskGene"},{"orgOrder":0,"company":"AskGene Pharma Inc","sponsor":"AffaMed Therapeutics","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"U.S.A","productType":"Large molecule","year":"2022","type":"Not Applicable","leadProduct":"ASKG712","moa":"VEGF","graph1":"Ophthalmology","graph2":"Phase I","graph3":"AskGene Pharma Inc","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"","sponsorNew":"AskGene Pharma Inc \/ AskGene Pharma","highestDevelopmentStatusID":"6","companyTruncated":"AskGene Pharma Inc \/ AskGene Pharma"}]

    Find Clinical Drug Pipeline Developments & Deals by AskGene Pharma Inc

    Menu

    AskGene Pharma Inc

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            AskGene Pharma Inc

                            U.S.A arrow
                            Antibody Engineering
                            Not Confirmed

                            AskGene Pharma Inc

                            U.S.A arrow
                            Antibody Engineering
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : ASKG712

                            Therapeutic Area : Ophthalmology

                            Study Phase : Phase I

                            Recipient : AffaMed Therapeutics

                            Deal Size : Not Applicable

                            Deal Type : Not Applicable

                            DEALS_DEV arrow-down

                            AffaMed Therapeutics Announces First Patient Dosed in the US Phase 1 Clinical Trial of AM712 in Retinal Diseas...

                            Details : In pre-clinical studies, AM712 (ASKG712) demonstrated robust efficacy, good ocular pharmacokinetics, and the desired safety profile supporting clinical exploration. AM712 is a novel bispecific biologic molecule specifically designed for ocular use.

                            Brand Name : AM712

                            Molecule Type : Large molecule

                            Upfront Cash : Not Applicable

                            May 30, 2022

                            Lead Product(s) : ASKG712

                            Therapeutic Area : Ophthalmology

                            Highest Development Status : Phase I

                            Recipient : AffaMed Therapeutics

                            Deal Size : Not Applicable

                            Deal Type : Not Applicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            AskGene Pharma Inc

                            U.S.A arrow
                            Antibody Engineering
                            Not Confirmed

                            AskGene Pharma Inc

                            U.S.A arrow
                            Antibody Engineering
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Single-domain Antibody

                            Therapeutic Area : Oncology

                            Study Phase : Discovery

                            Recipient : GenScript ProBio

                            Deal Size : Undisclosed

                            Deal Type : Licensing Agreement

                            DEALS_DEV arrow-down

                            GenScript ProBio and AskGene Enter into a Non-exclusive License of A sdAb Targeting Immune Checkpoint Target

                            Details : The single-domain antibodies involved in this license agreement will be paired with AskGene's proprietary next-generation cytokine therapeutics for cancer immunotherapy and other applications.

                            Brand Name : Undisclosed

                            Molecule Type : Large molecule

                            Upfront Cash : Undisclosed

                            September 26, 2021

                            Lead Product(s) : Single-domain Antibody

                            Therapeutic Area : Oncology

                            Highest Development Status : Discovery

                            Recipient : GenScript ProBio

                            Deal Size : Undisclosed

                            Deal Type : Licensing Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth